US798959A
(en)
|
1904-12-19 |
1905-09-05 |
George W Goss |
Corn-husker.
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
JPS6098584A
(ja)
|
1983-11-02 |
1985-06-01 |
Canon Inc |
カメラ―体形vtr
|
US5807715A
(en)
|
1984-08-27 |
1998-09-15 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
|
US4970198A
(en)
|
1985-10-17 |
1990-11-13 |
American Cyanamid Company |
Antitumor antibiotics (LL-E33288 complex)
|
US4676980A
(en)
|
1985-09-23 |
1987-06-30 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Target specific cross-linked heteroantibodies
|
US6548640B1
(en)
|
1986-03-27 |
2003-04-15 |
Btg International Limited |
Altered antibodies
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
US5037651A
(en)
|
1987-01-30 |
1991-08-06 |
American Cyanamid Company |
Dihydro derivatives of LL-E33288 antibiotics
|
US5079233A
(en)
|
1987-01-30 |
1992-01-07 |
American Cyanamid Company |
N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
|
JP3101690B2
(ja)
|
1987-03-18 |
2000-10-23 |
エス・ビィ・2・インコーポレイテッド |
変性抗体の、または変性抗体に関する改良
|
US5053394A
(en)
|
1988-09-21 |
1991-10-01 |
American Cyanamid Company |
Targeted forms of methyltrithio antitumor agents
|
US5606040A
(en)
|
1987-10-30 |
1997-02-25 |
American Cyanamid Company |
Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
|
US5770701A
(en)
|
1987-10-30 |
1998-06-23 |
American Cyanamid Company |
Process for preparing targeted forms of methyltrithio antitumor agents
|
ATE102631T1
(de)
|
1988-11-11 |
1994-03-15 |
Medical Res Council |
Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
|
IL115770A
(en)
*
|
1989-04-14 |
1999-03-12 |
American Cyanamid Co |
Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
AU6355090A
(en)
|
1989-08-23 |
1991-04-03 |
Scripps Clinic And Research Foundation |
Compositions and methods for detection and treatment of epstein-barr virus infection and immune disorders
|
US5959177A
(en)
|
1989-10-27 |
1999-09-28 |
The Scripps Research Institute |
Transgenic plants expressing assembled secretory antibodies
|
US6150584A
(en)
|
1990-01-12 |
2000-11-21 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
US5256643A
(en)
|
1990-05-29 |
1993-10-26 |
The Government Of The United States |
Human cripto protein
|
US5770429A
(en)
|
1990-08-29 |
1998-06-23 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
AU9016591A
(en)
|
1990-10-25 |
1992-05-26 |
Tanox Biosystems, Inc. |
Glycoproteins associated with membrane-bound immunoglobulins as antibody targets on B cells
|
DK0564531T3
(da)
|
1990-12-03 |
1998-09-28 |
Genentech Inc |
Berigelsesfremgangsmåde for variantproteiner med ændrede bindingsegenskaber
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
US5543503A
(en)
|
1991-03-29 |
1996-08-06 |
Genentech Inc. |
Antibodies to human IL-8 type A receptor
|
US5440021A
(en)
|
1991-03-29 |
1995-08-08 |
Chuntharapai; Anan |
Antibodies to human IL-8 type B receptor
|
DE69231223T3
(de)
|
1991-03-29 |
2008-01-17 |
Genentech, Inc., South San Francisco |
Menschliche pf4a rezeptoren und ihre verwendung
|
DE69233254T2
(de)
|
1991-06-14 |
2004-09-16 |
Genentech, Inc., South San Francisco |
Humanisierter Heregulin Antikörper
|
GB9114948D0
(en)
|
1991-07-11 |
1991-08-28 |
Pfizer Ltd |
Process for preparing sertraline intermediates
|
JP3050424B2
(ja)
|
1991-07-12 |
2000-06-12 |
塩野義製薬株式会社 |
ヒトエンドセリンリセプター
|
US5264557A
(en)
|
1991-08-23 |
1993-11-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Polypeptide of a human cripto-related gene, CR-3
|
US7018809B1
(en)
|
1991-09-19 |
2006-03-28 |
Genentech, Inc. |
Expression of functional antibody fragments
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
WO1993008829A1
(fr)
|
1991-11-04 |
1993-05-13 |
The Regents Of The University Of California |
Compositions induisant la destruction de cellules infectees par l'hiv
|
US6011146A
(en)
|
1991-11-15 |
2000-01-04 |
Institut Pasteur |
Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
|
US6153408A
(en)
|
1991-11-15 |
2000-11-28 |
Institut Pasteur And Institut National De La Sante Et De La Recherche Medicale |
Altered major histocompatibility complex (MHC) determinant and methods of using the determinant
|
DE69333807T2
(de)
|
1992-02-06 |
2006-02-02 |
Chiron Corp., Emeryville |
Marker für krebs und biosynthetisches bindeprotein dafür
|
IL107366A
(en)
|
1992-10-23 |
2003-03-12 |
Chugai Pharmaceutical Co Ltd |
Genes coding for megakaryocyte potentiator
|
US5644033A
(en)
|
1992-12-22 |
1997-07-01 |
Health Research, Inc. |
Monoclonal antibodies that define a unique antigen of human B cell antigen receptor complex and methods of using same for diagnosis and treatment
|
US5869445A
(en)
|
1993-03-17 |
1999-02-09 |
University Of Washington |
Methods for eliciting or enhancing reactivity to HER-2/neu protein
|
US5801005A
(en)
|
1993-03-17 |
1998-09-01 |
University Of Washington |
Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated
|
JPH08511420A
(ja)
|
1993-06-16 |
1996-12-03 |
セルテック・セラピューテイクス・リミテッド |
抗 体
|
US5773223A
(en)
|
1993-09-02 |
1998-06-30 |
Chiron Corporation |
Endothelin B1, (ETB1) receptor polypeptide and its encoding nucleic acid methods, and uses thereof
|
US5773001A
(en)
|
1994-06-03 |
1998-06-30 |
American Cyanamid Company |
Conjugates of methyltrithio antitumor agents and intermediates for their synthesis
|
US5750370A
(en)
|
1995-06-06 |
1998-05-12 |
Human Genome Sciences, Inc. |
Nucleic acid encoding human endothlein-bombesin receptor and method of producing the receptor
|
US5789199A
(en)
|
1994-11-03 |
1998-08-04 |
Genentech, Inc. |
Process for bacterial production of polypeptides
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
US5840523A
(en)
|
1995-03-01 |
1998-11-24 |
Genetech, Inc. |
Methods and compositions for secretion of heterologous polypeptides
|
US5869046A
(en)
|
1995-04-14 |
1999-02-09 |
Genentech, Inc. |
Altered polypeptides with increased half-life
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
US5712374A
(en)
*
|
1995-06-07 |
1998-01-27 |
American Cyanamid Company |
Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
|
US5707829A
(en)
|
1995-08-11 |
1998-01-13 |
Genetics Institute, Inc. |
DNA sequences and secreted proteins encoded thereby
|
US6267958B1
(en)
|
1995-07-27 |
2001-07-31 |
Genentech, Inc. |
Protein formulation
|
US20020193567A1
(en)
|
1995-08-11 |
2002-12-19 |
Genetics Institute, Inc. |
Secreted proteins and polynucleotides encoding them
|
JP3646191B2
(ja)
|
1996-03-19 |
2005-05-11 |
大塚製薬株式会社 |
ヒト遺伝子
|
CA2254843A1
(fr)
|
1996-05-17 |
1997-11-27 |
Schering Corporation |
Antigenes de lymphocytes b humains, reactifs apparentes
|
US5945511A
(en)
|
1997-02-20 |
1999-08-31 |
Zymogenetics, Inc. |
Class II cytokine receptor
|
US7033827B2
(en)
|
1997-02-25 |
2006-04-25 |
Corixa Corporation |
Prostate-specific polynucleotide compositions
|
US20030185830A1
(en)
|
1997-02-25 |
2003-10-02 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
US6541212B2
(en)
|
1997-03-10 |
2003-04-01 |
The Regents Of The University Of California |
Methods for detecting prostate stem cell antigen protein
|
DE69824287T2
(de)
|
1997-03-10 |
2005-06-16 |
The Regents Of The University Of California, Oakland |
Prostata stammzell-antigen (psca)
|
US6261791B1
(en)
|
1997-03-10 |
2001-07-17 |
The Regents Of The University Of California |
Method for diagnosing cancer using specific PSCA antibodies
|
US6555339B1
(en)
|
1997-04-14 |
2003-04-29 |
Arena Pharmaceuticals, Inc. |
Non-endogenous, constitutively activated human protein-coupled receptors
|
US6319688B1
(en)
|
1997-04-28 |
2001-11-20 |
Smithkline Beecham Corporation |
Polynucleotide encoding human sodium dependent phosphate transporter (IPT-1)
|
JP4213224B2
(ja)
|
1997-05-02 |
2009-01-21 |
ジェネンテック,インコーポレーテッド |
ヘテロマルチマー及び共通成分を有する多重特異性抗体の製造方法
|
US6890749B2
(en)
|
1997-05-15 |
2005-05-10 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
WO1998051824A1
(fr)
|
1997-05-15 |
1998-11-19 |
Abbott Laboratories |
Reactifs et procedes utiles au depistage de maladies du tractus urinaire
|
US6171586B1
(en)
|
1997-06-13 |
2001-01-09 |
Genentech, Inc. |
Antibody formulation
|
US6040498A
(en)
|
1998-08-11 |
2000-03-21 |
North Caroline State University |
Genetically engineered duckweed
|
US6602677B1
(en)
|
1997-09-19 |
2003-08-05 |
Promega Corporation |
Thermostable luciferases and methods of production
|
US20030060612A1
(en)
|
1997-10-28 |
2003-03-27 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
US20020034749A1
(en)
|
1997-11-18 |
2002-03-21 |
Billing-Medel Patricia A. |
Reagents and methods useful for detecting diseases of the breast
|
US6610833B1
(en)
|
1997-11-24 |
2003-08-26 |
The Institute For Human Genetics And Biochemistry |
Monoclonal human natural antibodies
|
US6110695A
(en)
|
1997-12-02 |
2000-08-29 |
The Regents Of The University Of California |
Modulating the interaction of the chemokine, B Lymphocyte Hemoattractant, and its Receptor, BLR1
|
WO1999029888A1
(fr)
|
1997-12-05 |
1999-06-17 |
The Scripps Research Institute |
Humanisation d'anticorps murins
|
JP4603157B2
(ja)
|
1998-03-13 |
2010-12-22 |
ザ バーナム インスティチュート |
種々の選択された器官または組織にホーミングする分子
|
US6194551B1
(en)
|
1998-04-02 |
2001-02-27 |
Genentech, Inc. |
Polypeptide variants
|
EP1068241B1
(fr)
|
1998-04-02 |
2007-10-10 |
Genentech, Inc. |
Variants d'anticorps et fragments de ceux-ci
|
CA2685270C
(fr)
|
1998-05-13 |
2014-07-29 |
Pharmexa Inc. |
Vecteurs d'expression destines a stimuler une reponse immunitaire et procedes de leur utilisation
|
US20030064397A1
(en)
|
1998-05-22 |
2003-04-03 |
Incyte Genomics, Inc. |
Transmembrane protein differentially expressed in prostate and lung tumors
|
US20020187472A1
(en)
|
2001-03-09 |
2002-12-12 |
Preeti Lal |
Steap-related protein
|
WO2000012130A1
(fr)
|
1998-08-27 |
2000-03-09 |
Smithkline Beecham Corporation |
Agonistes et antagonistes de rp105
|
JP4689781B2
(ja)
|
1998-09-03 |
2011-05-25 |
独立行政法人科学技術振興機構 |
アミノ酸輸送蛋白及びその遺伝子
|
WO2000020579A1
(fr)
|
1998-10-02 |
2000-04-13 |
Mcmaster University |
Forme epissee de l'oncogene erbb-2/neu
|
US6858710B2
(en)
|
1998-12-17 |
2005-02-22 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6468546B1
(en)
|
1998-12-17 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for therapy and diagnosis of ovarian cancer
|
US20020119158A1
(en)
|
1998-12-17 |
2002-08-29 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US6962980B2
(en)
|
1999-09-24 |
2005-11-08 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20030091580A1
(en)
|
2001-06-18 |
2003-05-15 |
Mitcham Jennifer L. |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
EP1141017B1
(fr)
|
1998-12-30 |
2008-09-10 |
Beth Israel Deaconess Medical Center, Inc. |
Caracterisation d'une famille de canaux calciques
|
PL209786B1
(pl)
|
1999-01-15 |
2011-10-31 |
Genentech Inc |
Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
HUP0105303A2
(en)
|
1999-01-29 |
2002-05-29 |
Corixa Corp |
Her-2/neu fusion proteins
|
GB9905124D0
(en)
|
1999-03-05 |
1999-04-28 |
Smithkline Beecham Biolog |
Novel compounds
|
US7465785B2
(en)
|
1999-03-08 |
2008-12-16 |
Genentech, Inc. |
Polypeptide encoded by a nucleic acid over-expressed in melanoma
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
US7312303B2
(en)
|
1999-05-11 |
2007-12-25 |
Genentech, Inc. |
Anti-PRO4980 antibodies
|
US20060073150A1
(en)
|
2001-09-06 |
2006-04-06 |
Mary Faris |
Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer
|
AU4952600A
(en)
|
1999-06-03 |
2000-12-28 |
Takeda Chemical Industries Ltd. |
Screening method with the use of cd100
|
ES2662581T3
(es)
|
1999-06-25 |
2018-04-09 |
Immunogen, Inc. |
Métodos de tratamiento usando conjugados de anticuerpo anti-ErbB-maitansinoide
|
US20030119113A1
(en)
|
1999-07-20 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7297770B2
(en)
|
1999-08-10 |
2007-11-20 |
Genentech, Inc. |
PRO6496 polypeptides
|
US7294696B2
(en)
|
1999-08-17 |
2007-11-13 |
Genentech Inc. |
PRO7168 polypeptides
|
EP1208202A2
(fr)
|
1999-09-01 |
2002-05-29 |
Genentech, Inc. |
Polypeptides secretes et transmembranaires et acides nucleiques codant pour ceux-ci
|
US20030206918A1
(en)
|
1999-09-10 |
2003-11-06 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20030232056A1
(en)
|
1999-09-10 |
2003-12-18 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US20030129192A1
(en)
|
1999-09-10 |
2003-07-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of ovarian cancer
|
US7125978B1
(en)
|
1999-10-04 |
2006-10-24 |
Medicago Inc. |
Promoter for regulating expression of foreign genes
|
AU782626B2
(en)
|
1999-10-04 |
2005-08-18 |
Medicago Inc. |
Method for regulating transcription of foreign genes
|
DE60039448D1
(de)
|
1999-10-29 |
2008-08-21 |
Genentech Inc |
Gegen das prostata-stammzellantigen (psca) gerichtete antikörper und deren verwendung
|
EP1235847B1
(fr)
|
1999-11-29 |
2016-01-20 |
The Trustees of Columbia University in the City of New York |
ISOLEMENT DE CINQ NOUVEAUX GENES CODANT POUR DES NOUVEAUX RECEPTEURS Fc DE TYPE MELANOME INTERVENANT DANS LA PATHOGENESE DU LYMPHOME MALIN ET DU MELANOME
|
CA2392510A1
(fr)
|
1999-11-30 |
2001-06-07 |
Corixa Corporation |
Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
|
JP2003530083A
(ja)
|
1999-12-10 |
2003-10-14 |
エピミューン インコーポレイテッド |
ペプチドおよび核酸組成物を使用する、HER2/neuに対する細胞性免疫応答の誘導
|
US20030180714A1
(en)
|
1999-12-15 |
2003-09-25 |
Genentech, Inc. |
Shotgun scanning
|
EP1246846B1
(fr)
|
1999-12-23 |
2008-09-10 |
ZymoGenetics, Inc. |
Recepteur soluble de l'interleukine-20
|
US6610286B2
(en)
|
1999-12-23 |
2003-08-26 |
Zymogenetics, Inc. |
Method for treating inflammation using soluble receptors to interleukin-20
|
NZ502058A
(en)
|
1999-12-23 |
2003-11-28 |
Ovita Ltd |
Isolated mutated nucleic acid molecule for regulation of ovulation rate
|
JP2003535037A
(ja)
|
1999-12-23 |
2003-11-25 |
ザイモジェネティクス,インコーポレイティド |
炎症を治療する方法
|
US7294695B2
(en)
|
2000-01-20 |
2007-11-13 |
Genentech, Inc. |
PRO10268 polypeptides
|
US20030224379A1
(en)
|
2000-01-21 |
2003-12-04 |
Tang Y. Tom |
Novel nucleic acids and polypeptides
|
US20020039573A1
(en)
|
2000-01-21 |
2002-04-04 |
Cheever Martin A. |
Compounds and methods for prevention and treatment of HER-2/neu associated malignancies
|
AU2001243142A1
(en)
|
2000-02-03 |
2001-08-14 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
US20020142377A1
(en)
|
2000-02-22 |
2002-10-03 |
Glucksmann Maria Alexandra |
18607, a novel human calcium channel
|
US20030219806A1
(en)
|
2000-02-22 |
2003-11-27 |
Millennium Pharmaceuticals, Inc. |
Novel 18607, 15603, 69318, 12303, 48000, 52920, 5433, 38554, 57301, 58324, 55063, 52991, 59914, 59921 and 33751 molecules and uses therefor
|
US20040005561A1
(en)
|
2000-03-01 |
2004-01-08 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
AU2001245280A1
(en)
|
2000-03-07 |
2001-09-17 |
Hyseq, Inc. |
Novel nucleic acids and polypeptides
|
EP1268526A4
(fr)
|
2000-03-24 |
2004-09-08 |
Fahri Saatcioglu |
Molecules d'acide nucleique specifiques de la prostate ou des testicules, polypeptides, techniques de diagnostic, et traitement therapeutique
|
EP1268554A2
(fr)
|
2000-03-31 |
2003-01-02 |
IPF Pharmaceuticals GmbH |
Medicament et moyen diagnostique pour analyser le proteome de surface de cellules tumorales et inflammatoires, et pour traiter des maladies tumorales et inflammatoires, de preference au moyen d'une analyse specifique des recepteurs de chimiokines et de l'interaction de ligands recepteurs de chimioki
|
AU2001253140A1
(en)
|
2000-04-03 |
2001-10-15 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
Tumor markers in ovarian cancer
|
MXPA02009902A
(es)
|
2000-04-07 |
2003-06-17 |
Arena Pharm Inc |
Receptores acoplados a proteina g, conocidos, activados constitutivamente, no endogenos.
|
NZ521540A
(en)
|
2000-04-11 |
2004-09-24 |
Genentech Inc |
Multivalent antibodies and uses therefor
|
US20030119115A1
(en)
|
2000-05-17 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
WO2001088133A2
(fr)
|
2000-05-18 |
2001-11-22 |
Lexicon Genetics Incorporated |
Nouveaux homologues humains de semaphorine et polynucleotides codant ceux-ci
|
AU2001274888A1
(en)
|
2000-05-19 |
2001-12-03 |
Human Genome Sciences, Inc. |
Nucleic acids, proteins, and antibodies
|
US20020051990A1
(en)
|
2000-06-09 |
2002-05-02 |
Eric Ople |
Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
|
WO2001098351A2
(fr)
|
2000-06-16 |
2001-12-27 |
Incyte Genomics, Inc. |
Recepteurs couples a la proteine g
|
EP1383892A2
(fr)
|
2000-06-30 |
2004-01-28 |
Incyte Genomics, Inc. |
Proteines de matricielles extracellulaires et d'adhesions cellulaires humaines
|
CA2406649A1
(fr)
|
2000-06-30 |
2002-01-10 |
Human Genome Sciences, Inc. |
Polynucleotides du type b7, polypeptides et anticorps en rapport
|
MXPA02012749A
(es)
|
2000-06-30 |
2003-10-06 |
Amgen Inc |
Moleculas semejantes a b7 y sus usos.
|
WO2002006339A2
(fr)
|
2000-07-03 |
2002-01-24 |
Curagen Corporation |
Nouvelles proteines et acides nucleiques les codant
|
US20040044179A1
(en)
|
2000-07-25 |
2004-03-04 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
AU2001283507A1
(en)
|
2000-07-27 |
2002-02-13 |
Mayo Foundation For Medical Education And Research |
B7-h3 and b7-h4, novel immunoregulatory molecules
|
WO2002010382A2
(fr)
|
2000-07-28 |
2002-02-07 |
Ulrich Wissenbach |
Marqueurs trp8, trp9 et trp10 associes au cancer
|
US7229623B1
(en)
|
2000-08-03 |
2007-06-12 |
Corixa Corporation |
Her-2/neu fusion proteins
|
CA2419533A1
(fr)
|
2000-08-14 |
2002-02-21 |
Corixa Corporation |
Compositions et methodes de traitement et de diagnostic de cancers associes a her-2/neu
|
AU2001283360A1
(en)
|
2000-08-14 |
2002-02-25 |
Corixa Corporation |
Methods for diagnosis and therapy of hematological and virus-associated malignancies
|
EP1311674A2
(fr)
|
2000-08-24 |
2003-05-21 |
Genentech, Inc. |
Compositions et procedes de diagnostic et traitement de tumeurs
|
GB0020953D0
(en)
|
2000-08-24 |
2000-10-11 |
Smithkline Beecham Biolog |
Vaccine
|
CA2421949A1
(fr)
|
2000-09-11 |
2002-03-21 |
Hyseq, Inc. |
Noveaux acides nucleiques et polypeptides
|
US20060073551A1
(en)
|
2000-09-15 |
2006-04-06 |
Genentech, Inc. |
Pro4487 polypeptides
|
WO2002022153A2
(fr)
|
2000-09-15 |
2002-03-21 |
Zymogenetics, Inc. |
Procede permettant de traiter l'inflammation
|
US6613567B1
(en)
|
2000-09-15 |
2003-09-02 |
Isis Pharmaceuticals, Inc. |
Antisense inhibition of Her-2 expression
|
AU2001292724B2
(en)
|
2000-09-18 |
2005-05-26 |
Biogen Idec Ma Inc. |
CRIPTO mutant and uses thereof
|
UA83458C2
(uk)
|
2000-09-18 |
2008-07-25 |
Байоджен Айдек Ма Інк. |
Виділений поліпептид baff-r (рецептор фактора активації в-клітин сімейства tnf)
|
JP2005506033A
(ja)
|
2000-10-13 |
2005-03-03 |
イーオーエス バイオテクノロジー インコーポレイテッド |
前立腺癌の診断法、前立腺癌モジュレータースクリーニングの組成物及び方法
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
CA2428242A1
(fr)
|
2000-11-07 |
2002-05-16 |
Zymogenetics, Inc. |
Recepteur humain de facteur de necrose tumorale
|
US20020150573A1
(en)
|
2000-11-10 |
2002-10-17 |
The Rockefeller University |
Anti-Igalpha-Igbeta antibody for lymphoma therapy
|
TWI313299B
(en)
|
2000-11-30 |
2009-08-11 |
Medarex Inc |
Transgenic transchromosomal rodents for making human antibodies
|
WO2002061087A2
(fr)
|
2000-12-19 |
2002-08-08 |
Lifespan Biosciences, Inc. |
Peptides antigeniques destines a des recepteurs couples a la proteine g (gpcr), anticorps s'y rapportant, et systeme d'identification desdits peptides antigeniques
|
EP1357828A2
(fr)
|
2001-01-12 |
2003-11-05 |
University of Medicine and Dentistry of New Jersey |
Proteine morphogenetique osseuse 2 (bmp-2) utilisee dans le traitement et le diagnostic du cancer
|
US20030119133A1
(en)
|
2001-01-16 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US20030119125A1
(en)
|
2001-01-16 |
2003-06-26 |
Genentech, Inc. |
Secreted and transmembrane polypeptides and nucleic acids encoding the same
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
EP1425302A2
(fr)
|
2001-01-24 |
2004-06-09 |
Protein Design Labs |
Procedes de diagnostic du cancer du sein, compositions et procedes de criblage de modulateurs du cancer du sein
|
US20030073144A1
(en)
|
2001-01-30 |
2003-04-17 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of pancreatic cancer
|
WO2002064780A1
(fr)
|
2001-02-12 |
2002-08-22 |
Bionomics Limited |
Sequences d'adn pour genes suppresseurs de tumeurs humains
|
AU2002258518A1
(en)
|
2001-03-14 |
2002-09-24 |
Millennium Pharmaceuticals, Inc. |
Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer
|
US20040236091A1
(en)
|
2001-03-28 |
2004-11-25 |
Chicz Roman M. |
Translational profiling
|
WO2003008537A2
(fr)
|
2001-04-06 |
2003-01-30 |
Mannkind Corporation |
Sequences d'epitope
|
US6820011B2
(en)
|
2001-04-11 |
2004-11-16 |
The Regents Of The University Of Colorado |
Three-dimensional structure of complement receptor type 2 and uses thereof
|
AU2002254615A1
(en)
|
2001-04-17 |
2002-10-28 |
The Board Of Trustees Of The University Of Arkansas |
Repeat sequences of the ca125 gene and their use for diagnostic and therapeutic interventions
|
CA2444691A1
(fr)
|
2001-04-18 |
2002-10-31 |
Protein Design Labs, Inc. |
Procedes de diagnostic du cancer du poumon, compositions et procedes de criblage de modulateurs du cancer du poumon
|
GEP20074091B
(en)
|
2001-04-26 |
2007-04-25 |
Biogen Idec Inc |
Cripto blocking antibodies and uses thereof
|
EP1515982A4
(fr)
|
2001-05-09 |
2005-10-26 |
Corixa Corp |
Methodes et compositions pour la therapie et le diagnostic du cancer de la prostate
|
AU2002344326A1
(en)
|
2001-05-11 |
2002-11-25 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acid sequence encoding ovarian antigen, ca125, and uses thereof
|
EA007275B1
(ru)
|
2001-05-24 |
2006-08-25 |
Займодженетикс, Инк. |
Слитые белки taci-иммуноглобулина
|
US7157558B2
(en)
|
2001-06-01 |
2007-01-02 |
Genentech, Inc. |
Polypeptide encoded by a polynucleotide overexpresses in tumors
|
AU2002314901A1
(en)
|
2001-06-04 |
2002-12-16 |
Eos Biotechnology, Inc. |
Methods of diagnosis and treatment of androgen-dependent prostate cancer, prostate cancer undergoing androgen-withdrawal, and androgen-independent prostate cancer
|
WO2003000842A2
(fr)
|
2001-06-04 |
2003-01-03 |
Curagen Corporation |
Nouvelles proteines et acides nucleiques codant pour de telles proteines
|
ATE483976T1
(de)
|
2001-06-05 |
2010-10-15 |
Exelixis Inc |
Gfats als modifikatoren des p53-wegs und verwendungsverfahren
|
JP2005505257A
(ja)
|
2001-06-05 |
2005-02-24 |
エクセリクシス・インコーポレイテッド |
p53経路のモディファイヤーとしてのIGsおよび使用方法
|
US7235358B2
(en)
|
2001-06-08 |
2007-06-26 |
Expression Diagnostics, Inc. |
Methods and compositions for diagnosing and monitoring transplant rejection
|
WO2002101075A2
(fr)
|
2001-06-13 |
2002-12-19 |
Millennium Pharmaceuticals, Inc. |
Identification, evaluation, prevention et traitement du cancer du col de l'uterus : nouveaux genes, nouvelles compositions, nouvelles trousses et nouvelles methodes
|
WO2002102235A2
(fr)
|
2001-06-18 |
2002-12-27 |
Eos Biotechnology Inc. |
Procedes de diagnostic du cancer ovarien, compositions et procedes de criblage de modulateurs du cancer ovarien
|
US7189507B2
(en)
|
2001-06-18 |
2007-03-13 |
Pdl Biopharma, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
US7705120B2
(en)
|
2001-06-21 |
2010-04-27 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
|
US20030108958A1
(en)
|
2001-06-28 |
2003-06-12 |
Rene De Waal Malefyt |
Biological activity of AK155
|
WO2003004529A2
(fr)
|
2001-07-02 |
2003-01-16 |
Licentia Ltd. |
Materiaux de recepteur ephrine-tie et leurs procedes
|
US20040076955A1
(en)
|
2001-07-03 |
2004-04-22 |
Eos Biotechnology, Inc. |
Methods of diagnosis of bladder cancer, compositions and methods of screening for modulators of bladder cancer
|
WO2003003984A2
(fr)
|
2001-07-05 |
2003-01-16 |
Curagen Corporation |
Nouvelles proteines et nouveaux acides nucleiques codant ces proteines
|
WO2003055439A2
(fr)
|
2001-07-18 |
2003-07-10 |
The Regents Of The University Of California |
Antigene cible her2/neu et son utilisation pour stimuler une reponse immunitaire
|
US20030108963A1
(en)
|
2001-07-25 |
2003-06-12 |
Millennium Pharmaceuticals, Inc. |
Novel genes, compositions, kit, and methods for identification, assessment, prevention and therapy of prostate cancer
|
BR0211614A
(pt)
|
2001-08-03 |
2006-10-31 |
Genentech Inc |
polipeptìdeo tacis e br3 e empregos dos mesmos
|
AU2002324700A1
(en)
|
2001-08-14 |
2003-03-03 |
Bayer Ag |
Nucleic acid and amino acid sequences involved in pain
|
US20030092013A1
(en)
|
2001-08-16 |
2003-05-15 |
Vitivity, Inc. |
Diagnosis and treatment of vascular disease
|
AU2002313559A1
(en)
|
2001-08-23 |
2003-03-10 |
Oxford Biomedica (Uk) Limited |
Genes
|
WO2003029262A2
(fr)
|
2001-08-29 |
2003-04-10 |
Vanderbilt University |
Recepteurs de mob-5 humains (il-24) et utilisations de ceux-ci
|
US20030124579A1
(en)
|
2001-09-05 |
2003-07-03 |
Eos Biotechnology, Inc. |
Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
|
CA2459219A1
(fr)
|
2001-09-17 |
2003-03-27 |
Protein Design Labs, Inc. |
Procedes de diagnostic du cancer, compositions et procedes de criblage de modulateurs du cancer
|
US20050004017A1
(en)
|
2001-09-18 |
2005-01-06 |
Yuval Reiss |
Methods and compositions for treating hcap associated diseases
|
MXPA04002593A
(es)
|
2001-09-18 |
2004-05-31 |
Genentech Inc |
Composiciones y metodos para el diagnostico y tratamiento de tumor.
|
WO2003025148A2
(fr)
|
2001-09-19 |
2003-03-27 |
Nuvelo, Inc. |
Nouveaux acides nucleiques et polypeptides
|
AU2002327792A1
(en)
|
2001-09-28 |
2003-04-07 |
Bing Yang |
Diagnosis and treatment of diseases caused by mutations in cd72
|
AU2002362454A1
(en)
|
2001-10-03 |
2003-04-14 |
Origene Technologies, Inc. |
Regulated breast cancer genes
|
AU2002362436A1
(en)
|
2001-10-03 |
2003-04-14 |
Rigel Pharmaceuticals, Inc. |
Modulators of lymphocyte activation and migration
|
US20050123925A1
(en)
|
2002-11-15 |
2005-06-09 |
Genentech, Inc. |
Compositions and methods for the diagnosis and treatment of tumor
|
CA2461665A1
(fr)
|
2001-10-19 |
2003-05-01 |
Genentech, Inc. |
Compositions et procedes pour le diagnostic et le traitement d'affections intestinales inflammatoires
|
CA2465268A1
(fr)
|
2001-10-24 |
2003-05-01 |
National Jewish Medical And Research Center |
Structures tridimensionnelles de tall-1 et de ses recepteurs parents, proteines modifiees et procedes associes
|
EP1440159B1
(fr)
|
2001-10-31 |
2006-12-27 |
Alcon, Inc. |
Proteines morphogeniques osseuses (bmp), recepteurs desdites proteines et proteines de liaison de ces proteines, et leur utilisation pour le diagnostic et le traitement du glaucome
|
WO2003042661A2
(fr)
|
2001-11-13 |
2003-05-22 |
Protein Design Labs, Inc. |
Methodes de diagnostic du cancer, compositions et methodes de criblage des modulateurs du cancer
|
US20030232350A1
(en)
|
2001-11-13 |
2003-12-18 |
Eos Biotechnology, Inc. |
Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
|
US7344843B2
(en)
|
2001-11-29 |
2008-03-18 |
Serono Genetics Institute S.A. |
Agonists and antagonists of prolixin for the treatment of metabolic disorders
|
AU2002349784A1
(en)
|
2001-12-03 |
2003-06-17 |
Asahi Kasei Pharma Corporation |
Nf-kappab activating genes
|
CA2469941A1
(fr)
|
2001-12-10 |
2003-07-03 |
Nuvelo, Inc. |
Nouveaux acides nucleiques et polypeptides
|
US20030134790A1
(en)
|
2002-01-11 |
2003-07-17 |
University Of Medicine And Dentistry Of New Jersey |
Bone Morphogenetic Protein-2 And Bone Morphogenetic Protein-4 In The Treatment And Diagnosis Of Cancer
|
US7452675B2
(en)
|
2002-01-25 |
2008-11-18 |
The Queen's Medical Center |
Methods of screening for TRPM4b modulators
|
WO2003072036A2
(fr)
|
2002-02-21 |
2003-09-04 |
Duke University |
Methodes therapeutiques utilisant des anticorps anti-cd22
|
CA2476518A1
(fr)
|
2002-02-22 |
2003-09-04 |
Genentech, Inc. |
Compositions et methodes de traitement de maladies relatives au systeme immunitaire
|
WO2003073823A2
(fr)
|
2002-03-01 |
2003-09-12 |
Exelixis, Inc. |
Pdpk1 utilises en tant que modificateurs de la voie p53 et procedes d'utilisation associes
|
WO2003101400A2
(fr)
|
2002-06-04 |
2003-12-11 |
Avalon Pharmaceuticals, Inc. |
Gene lie au cancer comme cible de chimiotherapie
|
EP2258712A3
(fr)
|
2002-03-15 |
2011-05-04 |
Multicell Immunotherapeutics, Inc. |
Compositions et procédés permettant d'initier ou d'ameliorer les réponses des cellules T limitées par le complexe majeur d 'histocompatibilité de classe I ou II et un anticorps au moyen de motifs d'ARN non codants immunomodulateurs
|
WO2004000997A2
(fr)
|
2002-03-19 |
2003-12-31 |
Curagen Corporation |
Polypeptides therapeutiques, acides nucleiques les codant et principes d'utilisation
|
US7202033B2
(en)
|
2002-03-21 |
2007-04-10 |
Sunesis Pharmaceuticals, Inc. |
Identification of kinase inhibitors
|
US7193069B2
(en)
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
JP2005520566A
(ja)
|
2002-03-22 |
2005-07-14 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Cripto特異的抗体
|
JP2005521429A
(ja)
|
2002-03-25 |
2005-07-21 |
ユーエービー リサーチ ファウンデーション |
Fcレセプターホモログ、試薬およびこれらの使用
|
WO2003083074A2
(fr)
|
2002-03-28 |
2003-10-09 |
Idec Pharmaceuticals Corporation |
Nouvelles cibles geniques et ligands se liant a celles-ci pour le traitement et le diagnostic de carcinomes du colon
|
US20030194704A1
(en)
|
2002-04-03 |
2003-10-16 |
Penn Sharron Gaynor |
Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
|
BR0308953A
(pt)
|
2002-04-05 |
2006-03-14 |
Agensys Inc |
composições, proteìna, polinucleotìdeo, método de geração de uma resposta imune, método de detecção, composição farmacêutica, anticorpo ou seu fragmento, animal transgênico, hibridoma, método de fornecimento de um agente citotóxico ou agente de diagnóstico e método de inibição do crescimento de células cancerosas
|
WO2003087768A2
(fr)
|
2002-04-12 |
2003-10-23 |
Mitokor |
Cibles pour une intervention therapeutique identifiee dans le proteome mitochondrial
|
JP2005536190A
(ja)
|
2002-04-16 |
2005-12-02 |
ジェネンテック・インコーポレーテッド |
腫瘍の診断と治療のための組成物と方法
|
WO2003089904A2
(fr)
|
2002-04-17 |
2003-10-30 |
Baylor College Of Medicine |
Aib1 utilise en tant que marqueur pronostique et predicteur de la resistance a l'endocrinotherapie
|
WO2003093444A2
(fr)
|
2002-05-03 |
2003-11-13 |
Incyte Corporation |
Transporteurs et canaux ioniques
|
CA2485983A1
(fr)
|
2002-05-15 |
2003-11-27 |
Avalon Pharmaceuticals |
Gene lie au cancer utilise comme cible pour la chimiotherapie
|
AU2003232453A1
(en)
|
2002-05-30 |
2003-12-19 |
David K. Bol |
Human solute carrier family 7 member 11 (hslc7a11)
|
CA2488441C
(fr)
|
2002-06-03 |
2015-01-27 |
Genentech, Inc. |
Bibliotheques de phages et anticorps synthetiques
|
AU2003240495A1
(en)
|
2002-06-04 |
2003-12-19 |
Incyte Corporation |
Diagnostics markers for lung cancer
|
EP1513934B1
(fr)
|
2002-06-06 |
2011-03-02 |
Oncotherapy Science, Inc. |
Genes et polypeptides en rapport avec les cancers du colon chez l'homme
|
AU2003242633A1
(en)
|
2002-06-06 |
2003-12-22 |
Molecular Engines Laboratories |
Dudulin genes, non-human animal model: uses in human hematological disease
|
CA2488629A1
(fr)
|
2002-06-07 |
2003-12-18 |
Avalon Pharmaceuticals, Inc |
Gene lie au cancer servant de cible en chimiotherapie
|
WO2003105758A2
(fr)
|
2002-06-12 |
2003-12-24 |
Avalon Pharmaceuticals, Inc. |
Gene lie au cancer utilise comme cible pour la chimiotherapie
|
JP2005533794A
(ja)
|
2002-06-18 |
2005-11-10 |
アーケミックス コーポレイション |
アプタマー−毒素分子およびこれを使用する方法
|
US20040249130A1
(en)
|
2002-06-18 |
2004-12-09 |
Martin Stanton |
Aptamer-toxin molecules and methods for using same
|
CA2489803A1
(fr)
|
2002-06-20 |
2003-12-31 |
The Regents Of The University Of California |
Compositions et procedes de modulation de l'activite lymphocytaire
|
WO2004001004A2
(fr)
|
2002-06-21 |
2003-12-31 |
Johns Hopkins University School Of Medicine |
Marqueurs de l'endothelium tumoral associe a une membrane
|
AU2003281515A1
(en)
|
2002-07-19 |
2004-02-09 |
Cellzome Ag |
Protein complexes of cellular networks underlying the development of cancer and other diseases
|
CN1692127A
(zh)
|
2002-07-25 |
2005-11-02 |
健泰科生物技术公司 |
Taci抗体及其用途
|
JP2004121218A
(ja)
|
2002-08-06 |
2004-04-22 |
Jenokkusu Soyaku Kenkyusho:Kk |
気管支喘息または慢性閉塞性肺疾患の検査方法
|
WO2004015426A1
(fr)
|
2002-08-06 |
2004-02-19 |
Bayer Healthcare Ag |
Agents diagnostiques et therapeutiques contre des maladies associees au recepteur 5 de la chemokine cxc humain (cxcr5)
|
CA2495389A1
(fr)
|
2002-08-19 |
2004-02-26 |
Genentech, Inc. |
Compositions et methodes de diagnostic et de traitement des tumeurs
|
EP1572957A4
(fr)
|
2002-08-27 |
2007-10-10 |
Bristol Myers Squibb Pharma Co |
Identification de polynucleotides pour predire l'activite de composes interagissant avec et/ou modulant des proteines tyrosine kinases et/ou des voies de proteines tyrosine kinases dans des cellules mammaires
|
WO2004020595A2
(fr)
|
2002-08-29 |
2004-03-11 |
Five Prime Therapeutics, Inc. |
Nouveaux polypeptides humains codes par des polynucleotides
|
AU2002951346A0
(en)
|
2002-09-05 |
2002-09-26 |
Garvan Institute Of Medical Research |
Diagnosis of ovarian cancer
|
JP2005537800A
(ja)
|
2002-09-06 |
2005-12-15 |
マンカインド コーポレイション |
エピトープ配列
|
CA2498264A1
(fr)
|
2002-09-09 |
2004-05-13 |
Nura, Inc. |
Recepteurs couples a la proteine g et leurs utilisations
|
JP2004113151A
(ja)
|
2002-09-27 |
2004-04-15 |
Sankyo Co Ltd |
癌遺伝子及びその用途
|
EP1554309A2
(fr)
|
2002-10-03 |
2005-07-20 |
McGILL UNIVERSITY |
Agents de liaison d'antigenes carcinoembryonnaires (cea) permettant d'inverser les effets tumorigenes a mediation cea sur des cellules cancereuses humaines et leurs utilisations
|
EP1570078A4
(fr)
|
2002-10-04 |
2006-09-13 |
Van Andel Res Inst |
Sous classification moleculaire de tumeurs renales et decouverte de nouveaux marqueurs diagnostiques
|
US7361740B2
(en)
|
2002-10-15 |
2008-04-22 |
Pdl Biopharma, Inc. |
Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis
|
CA2499300A1
(fr)
|
2002-10-31 |
2004-05-21 |
Genentech, Inc. |
Methodes et compositions pouvant augmenter la production d'anticorps
|
CA2503748A1
(fr)
|
2002-11-08 |
2004-05-27 |
Genentech, Inc. |
Compositions et procedes de traitement des maladies liees aux cellules k naturelles
|
US20040146907A1
(en)
|
2002-11-13 |
2004-07-29 |
Genentech, Inc. |
Methods and compositions for detecting dysplasia
|
AU2003298650B2
(en)
|
2002-11-15 |
2010-03-11 |
Musc Foundation For Research Development |
Complement receptor 2 targeted complement modulators
|
CA2505919A1
(fr)
|
2002-11-15 |
2004-06-03 |
The Board Of Trustees Of The University Of Arkansas |
Gene ca125 et utilisation de celui-ci aux fins d'interventions diagnostiques et therapeutiques
|
WO2004046342A2
(fr)
|
2002-11-20 |
2004-06-03 |
Biogen Idec Inc. |
Nouvelles cibles geniques et ligands se liant a ces cibles dans le traitement et le diagnostic de carcinomes
|
WO2004047749A2
(fr)
|
2002-11-21 |
2004-06-10 |
University Of Utah Research Foundation |
Modulation purinergique d'odeur
|
AU2003298786A1
(en)
|
2002-11-26 |
2004-06-18 |
Protein Design Labs, Inc. |
Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
|
AU2003302774A1
(en)
|
2002-12-06 |
2004-06-30 |
Diadexus, Inc. |
Compositions, splice variants and methods relating to ovarian specific genes and proteins
|
JP2004198419A
(ja)
|
2002-12-13 |
2004-07-15 |
Bayer Healthcare Llc |
Timp1を用いた検出方法
|
HU227217B1
(en)
|
2002-12-16 |
2010-11-29 |
Genentech Inc |
Immunoglobulin variants and uses thereof
|
JP4898120B2
(ja)
|
2002-12-20 |
2012-03-14 |
アボット バイオセラピューティクス コーポレイション |
Gpr64に対する抗体とその利用法
|
US20050249671A9
(en)
|
2002-12-23 |
2005-11-10 |
David Parmelee |
Neutrokine-alpha conjugate, neutrokine-alpha complex, and uses thereof
|
CA2512536A1
(fr)
|
2003-01-08 |
2004-07-29 |
Bristol-Myers Squibb Company |
Biomarqueurs et methodes de determination d'une sensibilite aux modulateurs du facteur de croissance epidermique
|
US20050227301A1
(en)
|
2003-01-10 |
2005-10-13 |
Polgen |
Cell cycle progression proteins
|
WO2004063355A2
(fr)
|
2003-01-10 |
2004-07-29 |
Protein Design Labs, Inc. |
Nouveaux procedes de diagnostic d'un cancer metastatique, compositions et procedes de depister des modulateurs du cancer metastatique
|
EP1583820A4
(fr)
|
2003-01-14 |
2007-07-18 |
Bristol Myers Squibb Co |
Polynucleotides et polypeptides associes a la voie nf-kb
|
EP1583821A4
(fr)
|
2003-01-15 |
2007-07-18 |
Millennium Pharm Inc |
Methodes et compositions de traitement de troubles urologiques a l'aide de genes 44390, 54181, 211, 5687, 884, 1405, 636, 4421, 5410, 30905, 2045, 16405, 18560, 2047, 33751, 52872, 14063, 20739, 32544, 43239, 44373, 51164, 53010, 16852, 1587, 2207, 22245, 2387, 52908, 69112, 14990, 18547, 115, 579
|
CA2510003A1
(fr)
|
2003-01-16 |
2004-08-05 |
Genentech, Inc. |
Banques de phages anticorps synthetiques
|
AU2004205684A1
(en)
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
CA2516128A1
(fr)
|
2003-02-14 |
2004-09-02 |
Sagres Discovery, Inc. |
Nouvelles cibles therapeutiques pour le cancer
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
US7871607B2
(en)
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
US20030224411A1
(en)
|
2003-03-13 |
2003-12-04 |
Stanton Lawrence W. |
Genes that are up- or down-regulated during differentiation of human embryonic stem cells
|
EP3120861B1
(fr)
|
2003-11-06 |
2018-08-15 |
Seattle Genetics, Inc. |
Composés intermédiaires pour la préparation de conjugués d'auristatin avec des éléments de liaison
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
WO2005097832A2
(fr)
|
2004-03-31 |
2005-10-20 |
Genentech, Inc. |
Anticorps anti-tgf-$g(b) humanises
|
US7785903B2
(en)
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
NZ549872A
(en)
|
2004-04-13 |
2009-09-25 |
Hoffmann La Roche |
Anti-P-selectin antibodies
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ox40l抗體
|
CA2580141C
(fr)
*
|
2004-09-23 |
2013-12-10 |
Genentech, Inc. |
Anticorps et conjugues produits avec de la cysteine
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
EP2465870A1
(fr)
|
2005-11-07 |
2012-06-20 |
Genentech, Inc. |
Polypeptides de liaison dotés de séquences hypvervariables VH/VL diversifiées et consensuelles
|
WO2007064919A2
(fr)
|
2005-12-02 |
2007-06-07 |
Genentech, Inc. |
Polypeptides de liaison avec des sequences de diversite limitees
|
EP2016101A2
(fr)
|
2006-05-09 |
2009-01-21 |
Genentech, Inc. |
Polypeptides de liaison à squelettes optimisés
|
EP2035456A1
(fr)
|
2006-06-22 |
2009-03-18 |
Novo Nordisk A/S |
Production d'anticorps bispécifiques
|
JP5290276B2
(ja)
|
2007-05-08 |
2013-09-18 |
ジェネンテック, インコーポレイテッド |
システイン改変抗muc16抗体および抗体−薬物結合体
|
CN100592373C
(zh)
|
2007-05-25 |
2010-02-24 |
群康科技(深圳)有限公司 |
液晶显示面板驱动装置及其驱动方法
|
PE20090309A1
(es)
|
2007-06-04 |
2009-04-18 |
Wyeth Corp |
Conjugado portador-caliqueamicina y un metodo de deteccion de caliqueamicina
|
MX2010003718A
(es)
|
2007-10-19 |
2010-04-21 |
Genentech Inc |
Anticuerpos anti-tenb2 producidos por ingenieria de cisteina y conjugados de farmaco y anticuerpo.
|
EP2235064B1
(fr)
|
2008-01-07 |
2015-11-25 |
Amgen Inc. |
Méthode de fabrication de molécules hétérodimères fc d'anticorps utilisant les effets de conduite électrostatique
|
WO2011133886A2
(fr)
|
2010-04-23 |
2011-10-27 |
Genentech, Inc. |
Production de protéines hétéromultimères
|
AU2011265054B2
(en)
|
2010-06-08 |
2016-09-15 |
Genentech, Inc. |
Cysteine engineered antibodies and conjugates
|
EP2640727B1
(fr)
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Conjugués d'anticorps alaninyl-maytansinol
|
PT2691417T
(pt)
|
2011-03-29 |
2018-10-31 |
Roche Glycart Ag |
Variantes de fc de anticorpos
|
MA45326A
(fr)
|
2015-10-20 |
2018-08-29 |
Genentech Inc |
Conjugués calichéamicine-anticorps-médicament et procédés d'utilisation
|